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D950178 AnginalChaatPaininVeryElderlyPatientsWithSevereAortlcStenosie:Doeait PredictCoronary
ArteryDiaease
S.K. Sharma,S. Khan, V. Kakerala, J.A. Ambroae. TheCardiovascular
hrstitute,A4tSirra/Hospita/,NewYork,IVYUSA
Patients with severe aortic stenosis without angina usually have been shown
to have normal coronary arteries or non-obstructive coronaty artery disease
(CAD). However, the significance of the presence or absence of angina in
very elderly patients with aevere aortic stenosis is unknown. We evaluated
the presence of coexisting CAD in elderly patients (age 81 + 12 yeare) with
severe calcific aortic stenosis in relation to history of angina. Patients with
history of myocardial infarction or CABG were excluded. All patients were
referred for balloon aortic valvuloplasty from 1989 to 199$3(mean aoriic valve
area 0.55 &0.32 cm2). Cineangiograms and medical records were reviewed
for coronary anatomy and historical data in 90 patients. All angiograms were
interpreted visually by a single experienced angiographer, blinded to the
patient’s history. Results: Significant CAD (> 50% diameter stenoais) was
strongly associated with the presence of angina. Most symptomatic patients
had > 70% stenosis.
Stenosis Angina (n= 32) No sngina (n = 67)
> 70”/0 15 (650/o) 3 (4”/0)”
50-70% 3 (130/.) 9 (13%)
<50% 5 (22%) 55 (82”A)*
Conclusion: In this selected very elderly patient population with aevere
aortic stenosis, the preaenceof angina wasastrong determinant of significant
CAD; the absence of angina predicted non-significant stenosis.
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~951-1291 infiuenCeOfAgeand8e~onAngio9raPhi~
Changeinthe LipoproteinandCoronary
AtheroscierosiaStudy(LCAS)
J.A. Herd, M.S. West, L. Ferlic, C.M. Ballantine, A.M. Gotto, Jr.. Baylor
Collegeof Medicine,Houston,TX,USA
More data are needad on the CHD benefit of lipid lowering in the elderly
and women. LCAS randomized pts with angiographic CHD and LDL-C of
115-190 m~dl despite diet to fkrvastatin (FL) 20 mg bid or placebo for
2.5 yr; adjunctive cholestyramine was given when prerandomization LDL-C
remained 2160. The primary endpoint was per-lesion per-pt change by QCA
in minimum lumen diameter (MLD). Of the 340 pts with evaluable lesions,
25%wereaged 65+and 17%were women. Inplacebo pts, mean progression
(PR) wee lower among those aged 65+ than among those <65, and lower
among women than men (table). FL treatmentreducedPR to about the
same lower rate in both age groups (no significant differences in response
between the age groups), reduced PR in men, and revereed PR in women.
More women than men had LDL-C ? 130 mddl; with adjustment for this
difference, improvement in MLD with FL treatment was significantly better in
women than men (p c 0.05).
MsanPercentageChan9ein MLD sfter2.5 Yr
All d Age <65 Age 65+ Male Female
(n L340) (i.254) (ri=S6) (n= 263) (. =57)
Placebo –6.4 –7.3 –3.9 –6.9 -3.4
FL –2.4 –2.4 –2.6 –3.6 +2.4
Thua, lipid lowering by FL was as beneficial in older as in younger pts,
and women reaponded to treatment as well as or better than men.
D951 130 SeverityandMorphologicAbnormalitiesofAortic
andMitraiRegurgitationinthe Eideriy:The
CardiovascularHeaithStudy(CHS)
C.L. Reid, T. Kuroaaki, J.S. Gottdiener, J.M. Gardin. Universityof California,
Irvine,Orange,CA,USA
Aortic (AR) and mitral regurgitation (MR) represent important causes of car-
diovascular disease; however, the prevalence, severity, and morphology of
valvular regurgitation (REG) in a group of randomly selected elderly have not
been well-defined. In CHS, a multicenter NHLBI study, 5,201 subjects (age
?85 years) underwent two-dimensional (2D) and color Doppler echocardio-
graphic examinations. Severity of REG by color Doppler was defined as a
jetllefl atrial area of <20% (mild) and ?20% (mod-severe) for MR and jef/LV
outflow tract height <46 (mild)and 246Y0(mod-severe) for AR. Of 19.9%with
AR, 6.2% was mod-severe; of 30.1% with MR, 26:6% was mod-severe. Aor-
tic valve morphology by 2D echo ahowed increased prevalence of thickened
leaflets in aubjects with AR (29%) compared to no AR (22%, p < 0.001) but
the prevalence of thickened leaflets in mildand mod-severe AR subjects.was
similar (29 vs 31Yo).Dilated aortic root was present in 1.1% of those with AR
vs 0.46% with no AR (p < 0.05). Mitral valve morphology showed proiapse in
1.9%with and 0.53Y0without MR (p < 0.001) and was more frequent in those
with mcd-severe MR (3.9%.vs 1.2%, mild, p < 001). Thickened mitrai leaflets
was present in 11.6% with MR (13% mild; 6.5Y0mod-severe) vs 7.1% with
no MR (p c 0.001). Mitral annular calcification (10% vs 5.9%, p c 0.001) and
LVwall motion abnormalities (9.6% vs 5.6%, p -=0.001) were more common
in subjects with than without MR, but did not predict aeverity.
Conclusions:In randomly selected community dwelling elderly: 1) AR and
MR are common but mod-severe REG is unusual; 2) Morphologic abnormal-
ities by 2D echo, most commonly valve thickening, are more frequent in
those with AR or MR; and 3) Severity of REG cannot be predicted by valve
morphology in this elderly population.
D951 131 Predictor of Mortaiityin EideriyPatientsWithSevereAorticStenosis.A 5 YearFoiiow-up
H. Piern, L.V. Decourt, M. Wajngarten, C. Medeiros, A. Catani,
J.B. Serro-Azul, O. Gebara, A. Nueebacher, L.B.P. Pivotto,
A.C. Pereira-Barreto, G. Bellotfi. GeriatricCardiology,Hear?krstituta,S40
Pau/o,Brazi/
Recognition of the predictors of mottalify in elderly patients (pts) with aevere
aortic stenosis (AS) is important for clinical decisions. 56 pta (80.4 & 5.2
years) with severe AS (valve area 0.6+ 0.2 cmz andror LV-aortic gradient of
66.4 +20.6 mmHg) were followed biannually foiamean period of 72 months.
We analyzed the relation between mortality and aymptoms, EKG, and Echo
data by uni and multivariate analysis. 23% of the pts were asymptomatic and
77% symptomatic (dyspnea, angina or syncope). 32% of the pts died during
follow-up.
The following parameters had a positive correlation with mortality by
univariate analysis: increased age (p = 0.01), higher end-systolic volume (p
= 0.006), left atrial enlargement by EKG (p = 0.04), presence of left bundle
branch bhxk (p = 0.02), and presence of dyspnea (p = 0.0p3), while there
was a negative correlation (lower mortality) with: preaence of sinus rhythm (p
= 0.004) and absence of symptoms (p= 0.02). Muitivariate analysis showed
a positive correlation between mortality and increased age (p = 0.002) and
EKG left atrial enlargement (p = 0.002), and a negative correlation (iower
mortality) with the presence of sinua rhythm (p= 0.0007) and the absence of
symptoms (p= 0.04).
Inconclusion: 1.The most powerful predictors of mortality were increased
age, absence of sinus rhythm, left atrial enlargement by EKG and the pres-
ence of symptoms;2. The presence of symptoms isa more powerful predictor
of mortality than any Echo-derived index. 3. Elderly pts with severe AS but
asymptomatic and in sinus rhythm have a low risk of death, and a conserva-
tive approach is adequate in such cases.
a951 132 OiderPatientsWithNonvaivuiarAtriaiFibriiiationHaveLowerLeftAtriaiAppendageVelocities
DeapiteHigherLeftVentricularEjectionFraction
andSimiiarLeftAtrialSize
A. Ilercil, S.-S. Yao, A. Hla, J. Meisner, J. Strom, J. Shirani. AlbertEinstein
Collageof Medicine,Bronx,NY USA
Elderfy pts with nonvalvular atrial fibrillation (NVAF) are at higher riak of
embolism regardless of other risk factors. Low left atrial appendage (LAA)
velocities in NVAF predict increased risk of embolism. We studied 30 con-
s.5eutive pta [age 43-91 yrs (mean 70 + 11), 53Y0 men] with NVAF by
transthoracic and multilane transesophageal echocerdiography to evaluate
the effect of age on LAA velocities. The following were compared in pts
younger (n = 16, age 62 + 7 yrs) and older (n = 14, age 79 + 6 yre) than
70 yrs of age: LA diameter (D) and volume (V); LVD, mass (M), and EF;
LAA area (A) and V; LAA peak emptying and sum of peak emptying and
peak filling velocities (PE and PE+F); spontaneous echo contrast (SEC) and
mitral regurgitation (MR). There was no difference in LAD (4.7 + 0.4-vs-4.8
A 0.6 cm), LAV (93+ 38-vs-1OO+38 ml), LVM (248 + 96-vs-234 *76 g),
LAA A (5.9 + 2.9-vs-4.6 l 2.3 cmz) or LAA V (5.7 + 5.4-vs-3.6 * 3.4 ml)
between the 2 groups (all p = NS). Older pts, however, had lower LAA PE
(23 + 5-vs-34 + 17 cm/s, p = 0.01), lower PE+F (52 + 14-vs-72 + 35 crnls,
p = 0.03), smailer LV diastolic D (4.3 + 0,6-vs-4.9 + 1.0 cm, p = 0.04), and
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